ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 770,95
0,48%
Dow Jones
44 025,81
1,24%
DAX
21 042,00
0,18%
Brent Oil
78,63
-0,15%
Bitcoin
105 554,84
-0,58%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Eton Pharmaceuticals Inc (ETON) Cours

Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc (ETON)

NASDAQ
15,27
0,86
(5,97%)
Fermé 22 Janvier 10:00PM
Retardé de 15 minutes
14,44
-0,83
(-5,44%)
Après les heures de négociation: 1:24AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
14,44
Prix Achat
15,16
Prix Vente
18,11
Volume échangé
430 814
14,46 Fourchette du Jour 15,706
3,03 Plage de 52 semaines 15,37
Cap du marché
373,075M
Clôture Veille
14,41
Ouverture
14,46
Dernière Transaction
10
@
15.231
Dernière heure de transaction
Volume financier
US$ 6 525 116
VWAP
15,146
Volume moyen (3 m)
239 952
Actions en circulation
25 836 204
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-420,72
Bénéfice par action (BPA)
-0,04
Chiffre d'affairess
31,64M
Bénéfice net
-936k

À propos de Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.etonpharma.com
Siège social
Dover, Delaware, USA
Fondé
-
Eton Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ETON. Le dernier cours de clôture d'Eton Pharmaceuticals était de US$14,41. Au cours de la dernière année, les actions de Eton Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 3,03 à US$ 15,37.

Eton Pharmaceuticals compte actuellement 25 836 204 actions en circulation. La capitalisation boursière d'Eton Pharmaceuticals est de US$372,30 million. Eton Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -420.72.

ETON Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

06 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

03 Janvier 2025
Edgar (US Regulatory)

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

Adds an additional commercial and strategic rare disease product to Eton’s portfolioGalzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease DEER PARK...

03 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

20 Décembre 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Acquisition bolsters Eton’s commercial pediatric endocrinology portfolioProduct is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic...

20 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

17 Décembre 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

DEER PARK, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and...

17 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

12 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.32.121640735514.1415.3713.0925992814.140765CS
41.9515.61248999212.4915.3711.61225931913.34325664CS
125.97570.58476077978.46515.378.2423995211.79256179CS
2610.89306.760563383.5515.373.25191785589.4607731CS
5210.31249.6368038744.1315.373.031175478.09932614CS
15610.6276.0416666673.8415.371.951357874.91116145CS
2607.0495.13513513517.415.371.952099445.92294272CS

ETON - Frequently Asked Questions (FAQ)

What is the current Eton Pharmaceuticals share price?
The current share price of Eton Pharmaceuticals is US$ 14,44
How many Eton Pharmaceuticals shares are in issue?
Eton Pharmaceuticals has 25 836 204 shares in issue
What is the market cap of Eton Pharmaceuticals?
The market capitalisation of Eton Pharmaceuticals is USD 372,3M
What is the 1 year trading range for Eton Pharmaceuticals share price?
Eton Pharmaceuticals has traded in the range of US$ 3,03 to US$ 15,37 during the past year
What is the PE ratio of Eton Pharmaceuticals?
The price to earnings ratio of Eton Pharmaceuticals is -420,72
What is the cash to sales ratio of Eton Pharmaceuticals?
The cash to sales ratio of Eton Pharmaceuticals is 12,44
What is the reporting currency for Eton Pharmaceuticals?
Eton Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Eton Pharmaceuticals?
The latest annual turnover of Eton Pharmaceuticals is USD 31,64M
What is the latest annual profit for Eton Pharmaceuticals?
The latest annual profit of Eton Pharmaceuticals is USD -936k
What is the registered address of Eton Pharmaceuticals?
The registered address for Eton Pharmaceuticals is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Eton Pharmaceuticals website address?
The website address for Eton Pharmaceuticals is www.etonpharma.com
Which industry sector does Eton Pharmaceuticals operate in?
Eton Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
263,47M
DWTXDogwood Therapeutics Inc
US$ 3,18
(70,05%)
24,31M
USEGUS Energy Corp
US$ 3,74
(61,21%)
107,79M
DOGZDogness International Corporation
US$ 27,62
(52,60%)
1,95M
MYNAMynaric AG
US$ 0,6697
(50,83%)
3,72M
GOEVCanoo Inc
US$ 0,3748
(-72,24%)
41,38M
SHOTWSafety Shot Inc
US$ 0,1094
(-47,40%)
18,06k
ORKTOrangeKloud Technology Inc
US$ 0,7068
(-36,89%)
7,48M
HEPAHepion Pharmaceuticals Inc
US$ 0,3219
(-31,36%)
1,66M
WNWMeiwu Technology Company Ltd
US$ 0,2681
(-27,05%)
11,02M
GCTKGlucoTrack Inc
US$ 0,1226
(44,41%)
613,28M
CRKNCrown Electrokinetics Corporation
US$ 0,1121
(-10,32%)
392,52M
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
262,98M
RIMEAlgorhythm Holdings Inc
US$ 0,034599
(-16,83%)
230,08M
RGTIRigetti Computing Inc
US$ 13,97
(42,12%)
226,81M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ETON
Eton Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés